Modalis Therapeutics Statistics
Total Valuation
TYO:4883 has a market cap or net worth of JPY 5.11 billion. The enterprise value is 2.30 billion.
| Market Cap | 5.11B |
| Enterprise Value | 2.30B |
Important Dates
The last earnings date was Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:4883 has 86.67 million shares outstanding. The number of shares has increased by 67.52% in one year.
| Current Share Class | 86.67M |
| Shares Outstanding | 86.67M |
| Shares Change (YoY) | +67.52% |
| Shares Change (QoQ) | +6.55% |
| Owned by Insiders (%) | 9.18% |
| Owned by Institutions (%) | 10.60% |
| Float | 77.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.83 |
| P/TBV Ratio | 1.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.07 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.09 |
Financial Position
The company has a current ratio of 21.58
| Current Ratio | 21.58 |
| Quick Ratio | 20.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -245.67 |
Financial Efficiency
Return on equity (ROE) is -67.91% and return on invested capital (ROIC) is -43.61%.
| Return on Equity (ROE) | -67.91% |
| Return on Assets (ROA) | -41.53% |
| Return on Invested Capital (ROIC) | -43.61% |
| Return on Capital Employed (ROCE) | -78.13% |
| Weighted Average Cost of Capital (WACC) | 4.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -153.71M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TYO:4883 has paid 1.00 million in taxes.
| Income Tax | 1.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -43.56% in the last 52 weeks. The beta is 0.12, so TYO:4883's price volatility has been lower than the market average.
| Beta (5Y) | 0.12 |
| 52-Week Price Change | -43.56% |
| 50-Day Moving Average | 59.86 |
| 200-Day Moving Average | 76.15 |
| Relative Strength Index (RSI) | 38.58 |
| Average Volume (20 Days) | 498,490 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.21B |
| Pretax Income | -2.15B |
| Net Income | -2.15B |
| EBITDA | n/a |
| EBIT | -2.21B |
| Earnings Per Share (EPS) | -27.85 |
Balance Sheet
The company has 2.81 billion in cash and n/a in debt, with a net cash position of 2.81 billion or 32.44 per share.
| Cash & Cash Equivalents | 2.81B |
| Total Debt | n/a |
| Net Cash | 2.81B |
| Net Cash Per Share | 32.44 |
| Equity (Book Value) | 2.79B |
| Book Value Per Share | 33.62 |
| Working Capital | 2.76B |
Cash Flow
In the last 12 months, operating cash flow was -2.12 billion and capital expenditures -2.00 million, giving a free cash flow of -2.12 billion.
| Operating Cash Flow | -2.12B |
| Capital Expenditures | -2.00M |
| Free Cash Flow | -2.12B |
| FCF Per Share | -24.46 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TYO:4883 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -67.52% |
| Shareholder Yield | -67.52% |
| Earnings Yield | -42.08% |
| FCF Yield | -41.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |